While a new report from Goldman Sachs says health care is in a state of flux that most of the sector’s companies haven’t adjusted to yet, it also pinpoints four that have plenty of cash that could be put to good use for investo…
Giant U.S. pharmaceutical group Abbott Laboratories is cutting 3,000 jobs, or about 3% of its workforce, following its purchase of Belgian-based Solvay’s drugs business.
Continue reading Abbott to Layoff 3,000 …
A U.S. Food and Drug Administration advisory panel voted on Thursday in favor of expanding Alkermes’ alcohol addiction treatment drug, Vivitrol, to treat opioid addiction.
Continue reading Alkermes Opioid Addic…
It’s a busy day at the FDA today as panels meet to discuss two new drugs — one to help weight loss and the other to combat drug addiction — and decide whether to approve AstraZeneca’s new blood thinner medication.
…
Sanofi-Aventis CEO Chris Viehbacher said Wednesday that he believes his French pharmaceutical company will eventually buy U.S. biotech company Genzyme at a reasonable price. However, he expects it will take some time to agree o…